O-linoleoylcarnitine

Metabolite details

Identifier

MJLXQSQYKZWZCB-UTJQPWESSA-N

InChI Key

MJLXQSQYKZWZCB-UTJQPWESSA-N

IUPAC name

3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]-4-(trimethylazaniumyl)butanoate

Preferred name

O-linoleoylcarnitine

INN name

—

Synonym

linoleylcarnitine

ChEBI

CHEBI:73072

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic characterization of the natural progression of chronic hepatitis B (Biogenic amine and Acyl-carnitine assays).
• Tissue- and Pathway-Specific Metabolomic Profiles of the Steroid Receptor Coactivator (SRC) family
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Flow cytometry has a significant impact on the cellular metabolome (General LC-MS assay)
• Flow cytometry has a significant impact on the cellular metabolome (Lipidomic LC-MS assay)
• Integrated multi-omics analysis of adverse cardiac remodeling and metabolic inflexibility upon ErbB2 and ERRα deficiency.

Observed in differential profiles

• Control_vs_Immune_Tolerant
• Control_vs_Immune_Tolerant
• SRC1_Knockout_Fed_Liver_vs_SRC1_Wildtype_Fed_Liver
• SRC1_Knockout_Fed_Liver_vs_SRC1_Wildtype_Fed_Liver
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Ctrl_vs_Ab
• G1_Ctrl_vs_G2_Ab
• WT_vs_ErbB2_KI